ng-nitroarginine methyl ester has been researched along with Adenocarcinoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epifano, F; Fiorito, S; Genovese, S; Kochi, T; Mori, T; Moriwaki, H; Shimizu, M; Shirakami, Y; Tanaka, T | 1 |
| Benner, A; Berthel, A; Brand, K; Buechler, MW; Falk, CS; Grabe, N; Halama, N; Herrmann, T; Jaeger, D; Kahlert, C; Klupp, F; Koch, M; Krauss, J; Kunz, C; Lasitschka, F; Lerchl, T; Luckner-Minden, C; Luecke, S; Schneider, M; Springfeld, C; Suarez-Carmona, M; Suetterlin, T; Ulrich, A; Weitz, J; Zitvogel, L; Zoernig, I | 1 |
| Gustafsson, SB; Jacobsson, SO; Jonsson, M; Lindgren, T | 1 |
| Katiyar, SK; Punathil, T | 1 |
| Bhowmick, R; Girotti, AW | 1 |
| Bellone, M; Capuano, G; Freschi, M; Generoso, L; Grioni, M; Jachetti, E; Ricupito, A; Rigamonti, N | 1 |
| Bussolati, O; Dall'Asta, V; Gazzola, GC; Rotoli, BM; Sala, R | 1 |
| Lala, PK; Orucevic, A | 1 |
| Eckmann, L; Kagnoff, MF; Kim, JM; Witthöft, T | 1 |
| Bechberger, J; Billiar, TR; Green, AM; Lala, PK; Orucevic, A; Shapiro, RA | 1 |
| Chakraborty, C; Hum, KO; Jadeski, LC; Lala, PK | 1 |
| D'Agostino, A; Davel, L; De Lustig, ES; Eijan, AM; Español, A; Jasnis, MA; Lauría, L; Piccardo, I; Sales, ME | 1 |
| Hegardt, P; Kjellman, C; Li, L; Sjögren, B; Sjögren, HO; Sur, I; Widegren, B | 1 |
| Adrian, TE; Knezetic, JA; Thomas, DL; Thomas, WJ | 1 |
| Andrade, SP; Hart, IR; Piper, PJ | 1 |
15 other study(ies) available for ng-nitroarginine methyl ester and Adenocarcinoma
| Article | Year |
|---|---|
A newly synthesized compound, 4'-geranyloxyferulic acid-N(omega)-nitro-L-arginine methyl ester suppresses inflammation-associated colorectal carcinogenesis in male mice.
Topics: Adenocarcinoma; Adenoma; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinogenesis; Cell Proliferation; Colorectal Neoplasms; Coumaric Acids; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Inflammation; Intestinal Mucosa; Male; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Nitroarginine; RNA-Binding Proteins | 2014 |
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
Topics: Adenocarcinoma; Apoptosis; Chemokine CCL5; Chemokines; Chemotaxis; Clinical Trials, Phase I as Topic; Clodronic Acid; Colorectal Neoplasms; Cyclohexanes; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Maraviroc; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Pilot Projects; Pyridines; Receptors, CCR5; STAT3 Transcription Factor; Survival Analysis; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment | 2016 |
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antioxidants; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclic AMP; Dronabinol; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fatty Acids, Unsaturated; Fluorouracil; Humans; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Piperidines; Pyrazoles; Receptors, Cannabinoid; Thymidine; Tumor Cells, Cultured | 2009 |
Inhibition of non-small cell lung cancer cell migration by grape seed proanthocyanidins is mediated through the inhibition of nitric oxide, guanylate cyclase, and ERK1/2.
Topics: Adenocarcinoma; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cell Survival; Cyclic GMP; Enzyme Inhibitors; Fluorescent Antibody Technique; Grape Seed Extract; Guanylate Cyclase; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Plant Extracts; Proanthocyanidins; Quinoxalines; Receptors, Cell Surface; Signal Transduction; Tumor Cells, Cultured; Vitis | 2009 |
Cytoprotective induction of nitric oxide synthase in a cellular model of 5-aminolevulinic acid-based photodynamic therapy.
Topics: Adenocarcinoma; Aminolevulinic Acid; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Cytoprotection; Enzyme Activation; Epithelial Cells; Female; Humans; Light; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Photochemotherapy | 2010 |
Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer.
Topics: Adenocarcinoma; Animals; Arginine; CD11b Antigen; Cell Proliferation; Disease Progression; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelopoiesis; NG-Nitroarginine Methyl Ester; Piperazines; Prostatic Neoplasms; Purines; Sildenafil Citrate; Sulfones; T-Lymphocytes; Tumor Cells, Cultured | 2011 |
The transport of cationic amino acids in human airway cells: expression of system y+L activity and transepithelial delivery of NOS inhibitors.
Topics: Adenocarcinoma; Amino Acid Transport System y+L; Amino Acids; Animals; Arginine; Biological Transport; Cations; Cell Line; Cell Line, Tumor; Cell Membrane Permeability; Culture Media, Conditioned; Epithelial Cells; Gene Expression; Humans; Lung Neoplasms; Lysine; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Respiratory System; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Topics: Adenocarcinoma; Analysis of Variance; Animals; Antineoplastic Agents; Arginine; Capillary Permeability; Combined Modality Therapy; Female; Immunotherapy; Interleukin-2; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred C3H; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pleural Effusion, Malignant; Pulmonary Edema; Statistics, Nonparametric; Tumor Cells, Cultured | 1996 |
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells.
Topics: Adenocarcinoma; Cell Line; Colon; Colonic Neoplasms; Escherichia coli; Gene Expression Regulation, Enzymologic; Humans; Intestinal Mucosa; Kinetics; Lipopolysaccharides; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Polymerase Chain Reaction; RNA, Messenger; Salmonella; Shigella flexneri; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.
Topics: Adenocarcinoma; Animals; Enzyme Induction; Female; Gene Expression Regulation, Neoplastic; Interferon-gamma; Lipopolysaccharides; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Recombinant Proteins; Tissue Inhibitor of Metalloproteinase-3; Tumor Cells, Cultured | 1999 |
Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
Topics: Adenocarcinoma; Animals; Cell Cycle; Cell Division; Cell Movement; Enzyme Inhibitors; Female; Immunohistochemistry; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Invasiveness; Neoplasm Transplantation; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Tumor Cells, Cultured | 2000 |
Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.
Topics: Adenocarcinoma; Animals; Enzyme Inhibitors; Immunoblotting; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III | 2002 |
Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Cytokines; Dendritic Cells; DNA, Complementary; Enzyme Inhibitors; Female; Immunity, Cellular; Interferon-gamma; Interleukin-18; Macrophages; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred BN; Rats, Wistar; RNA; Spleen; Tumor Cells, Cultured | 2001 |
The role of oxygen-derived free radicals and nitric oxide in cytokine-induced antiproliferation of pancreatic cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Division; Cytokines; Enzyme Inhibitors; Free Radical Scavengers; Humans; Interferon-gamma; Interleukin-1; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Pancreatic Neoplasms; Protein Kinase C; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow | 1992 |